Copy Link Print Information

Moxetumomab

고객리뷰

Based on 1 Customer Validation

Moxetumomab is a CD22-targeting monoclonal antibody that forms the component of Moxetumomab Pasudotox, a recombinant CD22-targeting immunotoxin. Moxetumomab binds to CD22 on malignant B cells and delivers the PE38 toxin domain to tumor cells. Moxetumomab can be used in research on relapsed or refractory hairy cell leukemia.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Moxetumomab
  • Experimental Validation Results for Moxetumomab
  • Experimental Validation Results for Moxetumomab
  • Moxetumomab Chemical Structure
    Moxetumomab Chemical Structure
CAS No.: 1622075-65-3
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Moxetumomab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa

  • 1/16

    Immobilized Siglec-2/CD22 Protein, Human (512a.a, HEK293, His, HY-P73648) can bind Moxetumomab. The EC50 for this effect is 7.491 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Moxetumomab (anti-Siglec-2/CD22) (HY-P99034). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.

  • Moxetumomab Chemical Structure
    1/16
  • Moxetumomab
  • Immobilized Siglec-2/CD22 Protein, Human (512a.a, HEK293, His, HY-P73648) can bind Moxetumomab. The EC50 for this effect is 7.491 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Moxetumomab (anti-Siglec-2/CD22) (HY-P99034). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.
  • IgG1-kappa